The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

We have investigated the relation between nocturnal insulin requirements and nocturnal growth hormone (GH) release in 26 diabetic adolescents at various puberty stages and have examined the effect of nocturnal GH suppression on pre-breakfast insulin requirement. In all the studies, euglycaemia was m...

Podrobná bibliografie
Hlavní autoři:	Edge, J, Matthews, DR, Dunger, D
Médium:	Journal article
Jazyk:	English
Vydáno:	1990

Podobné jednotky

Increased overnight growth hormone concentrations in diabetic compared with normal adolescents.
Autor: Edge, J, a další
Vydáno: (1990)

Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.
Autor: Edge, J, a další
Vydáno: (1993)

Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes.
Autor: Edge, J, a další
Vydáno: (1990)

Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
Autor: Edge, J, a další
Vydáno: (1989)

Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty.
Autor: Dunger, D, a další
Vydáno: (1991)

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
Autor: Dunger, D, a další
Vydáno: (1991)

The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
Autor: Foot, AB, a další
Vydáno: (1990)

An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents.
Autor: Matthews, DR, a další
Vydáno: (1990)

The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
Autor: Pal, B, a další
Vydáno: (1993)

The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
Autor: Cheetham, T, a další
Vydáno: (1994)

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Autor: Massoud, A, a další
Vydáno: (1996)

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus.
Autor: Cheetham, T, a další
Vydáno: (1993)

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
Autor: A. V. Vitebskaya, a další
Vydáno: (2021-11-01)

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
Autor: Mullis, P, a další
Vydáno: (1992)

The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
Autor: Cheetham, T, a další
Vydáno: (1997)

Growth Hormone-Releasing Hormone in Diabetes
Autor: Leonid Evsey Fridlyand, a další
Vydáno: (2016-10-01)

Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
Autor: Pal, B, a další
Vydáno: (1992)

Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
Autor: Dunger, D, a další
Vydáno: (1993)

Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
Autor: Dunger, D, a další
Vydáno: (1993)

The correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus
Autor: Roman Gabriela, a další
Vydáno: (2016-03-01)

The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers.
Autor: Anderson, I, a další
Vydáno: (1989)

THE OVERNIGHT CONSULTANT /
Autor: Lewin, Marsha D. 242587
Vydáno: (1995)

Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Autor: Amin, R, a další
Vydáno: (2005)

The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH)
Autor: Suri, D, a další
Vydáno: (1991)

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
Autor: Hindmarsh, P, a další
Vydáno: (1991)

Growth-hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release.
Autor: Grossman, A, a další
Vydáno: (1983)

Growth hormone releasing hormone.
Autor: Grossman, A, a další
Vydáno: (1986)

Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph.
Autor: Brain, C, a další
Vydáno: (1988)

Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus
Autor: Wen Wu, a další
Vydáno: (2017-01-01)

THE CHARACTERISTICS OF GROWTH-HORMONE (GH) PULSATILITY IN NEONATES
Autor: Adcock, C, a další
Vydáno: (1994)

The effect of prolonged fasting on levels of growth hormone-binding protein and free growth hormone.
Autor: Salgin, B, a další
Vydáno: (2012)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
Autor: Korbonits, M, a další
Vydáno: (1998)

Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
Autor: Ross, R, a další
Vydáno: (1987)

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
Autor: Looij, B, a další
Vydáno: (1986)

The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
Autor: Achermann, J, a další
Vydáno: (1999)

A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring
Autor: Souptik Barua, a další
Vydáno: (2024-02-01)

The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
Autor: Spoudeas, H, a další
Vydáno: (1992)

GROWTH HORMONE-RELEASING HORMONE-TREATMENT OF GROWTH-HORMONE DEFICIENT CHILDREN
Autor: Ross, R, a další
Vydáno: (1986)

Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study.
Autor: Peyrot, M, a další
Vydáno: (2006)

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
Autor: Besser, G, a další
Vydáno: (1983)